CLEVELAND, Ohio — University Hospitals has begun the first steps toward building a $68.4 million world-class pathology ...

Researchers at Karolinska Institutet have developed a computational method capable of simulating the movements of some of the ...

In a groundbreaking study published in BME Frontiers , researchers from the University of California, Los Angeles (UCLA), in ...

Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr ...

New research assessing the efficacy of optical genome mapping (OGM) in a group of patients with acute leukemia has ...

Bionano Symposium 2026 continues with Day 2: New Frontiers in Oncology and Bioprocessing Applications on February 24, 2026, from 7:00-10:00 AM PT. Attendees may also explore scientific posters ...

When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or only MSI-positive tumors, accuracy fell substantially, revealing that the ...

URO-1, Inc. is a life sciences company dedicated to advancing the tools and workflows used in soft tissue biopsy diagnostics.

Dr. El-Gabry succeeds Mark Kockx, MD, PhD, CellCarta co-founder and long-serving Chief Medical Officer, who is stepping down from his executive responsibilities to focus on his health. Mark's ...

Scientists studying stranded pygmy sperm whales have uncovered three previously unknown genotypes of Helicobacter bacteria ...

How can rapid advancements in medical technology, questions about the criteria for brain death and the rise of transhumanism ...